The Alliance for Aging Research believes that all people should have access to high-quality healthcare.
The Alliance for Aging Research Joins Over 80 Groups in Urging Congress to Reject Methodologies that Reinforce Health Inequities
Published April 14, 2021
Over 80 national organizations representing patients and people with disabilities signed a letter to lawmakers urging them to reject policies that discriminate against people with disabilities and chronic conditions, older adults, and reinforce health inequities. The letter calls on policymakers to condemn policies that would rely on the Quality-Adjusted Life Year (QALY) or similar metrics that fail to account for those who are not average, and work to ensure the most vulnerable populations among us, including people with disabilities, will not be denied coverage or access to high quality health care based on discriminatory measurements of a treatment’s value.
The Alliance for Aging Research was pleased to sign this letter. Click here to read it. To read the official press release, please visit CancerCare‘s announcement here.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org
Media Contact:
Janelle Germanos
Communications Manager
[email protected]
(202) 688-1209